Invention Grant
- Patent Title: Cell-penetrating cereblon recombinant fusion protein and use thereof
-
Application No.: US17244975Application Date: 2021-04-30
-
Publication No.: US11358992B2Publication Date: 2022-06-14
- Inventor: SooHee Ryu , Hwa Jin Lee , Seong Hoon Kim , Hyeong Seok Lee
- Applicant: UPPTHERA
- Applicant Address: KR Incheon
- Assignee: UPPTHERA
- Current Assignee: UPPTHERA
- Current Assignee Address: KR Incheon
- Agent Nicholas Park
- Priority: KR10-2020-0046840 20200417
- Main IPC: C07K19/00
- IPC: C07K19/00 ; C07K14/47 ; A61K38/17 ; A61K45/06
Abstract:
The present invention relates to a novel cell-penetrating recombinant fusion protein including a peptide domain consisting of the amino acid sequence of SEQ ID NO: 1 and a peptide domain consisting of the amino acid sequence of SEQ ID NO: 2. The novel cell-penetrating cereblon recombinant fusion protein according to the present invention may be usefully employed in the prevention or treatment of cereblon-related diseases.
Public/Granted literature
- US20210324022A1 CELL-PENETRATING CEREBLON RECOMBINANT FUSION PROTEIN AND USE THEREOF Public/Granted day:2021-10-21
Information query
